These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 33296340)

  • 21. High prevalence of extended-spectrum ß-lactamase producing enterobacteriaceae among clinical isolates in Burkina Faso.
    Ouedraogo AS; Sanou M; Kissou A; Sanou S; Solaré H; Kaboré F; Poda A; Aberkane S; Bouzinbi N; Sano I; Nacro B; Sangaré L; Carrière C; Decré D; Ouégraogo R; Jean-Pierre H; Godreuil S
    BMC Infect Dis; 2016 Jul; 16():326. PubMed ID: 27400864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimicrobial resistance, multilocus sequence types and virulence profiles of ESBL producing and non-ESBL producing uropathogenic Escherichia coli isolated from cats and dogs in Switzerland.
    Zogg AL; Zurfluh K; Schmitt S; Nüesch-Inderbinen M; Stephan R
    Vet Microbiol; 2018 Mar; 216():79-84. PubMed ID: 29519530
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial Resistance and Molecular Characterization of Extended-Spectrum β-Lactamases of Escherichia coli and Klebsiella spp. Isolates from Urinary Tract Infections in Southern Brazil.
    Pereira JL; Volcão LM; Klafke GB; Vieira RS; Gonçalves CV; Ramis IB; da Silva PEA; von Groll A
    Microb Drug Resist; 2019 Mar; 25(2):173-181. PubMed ID: 30133334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence and risk of co-transmission of plasmid-mediated quinolone resistance and extended-spectrum β-lactamase genes in fluoroquinolone-resistant uropathogenic Escherichia coli: a first study from Kolkata, India.
    Basu S; Mukherjee M
    J Glob Antimicrob Resist; 2018 Sep; 14():217-223. PubMed ID: 29614372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and quinolone resistance of fecal carriage of extended-spectrum β-lactamase-producing Escherichia coli in 6 communities and 2 physical examination center populations in Shanghai, China.
    Ni Q; Tian Y; Zhang L; Jiang C; Dong D; Li Z; Mao E; Peng Y
    Diagn Microbiol Infect Dis; 2016 Dec; 86(4):428-433. PubMed ID: 27681363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New Delhi metallo-β-lactamase and extended spectrum β-lactamases co-producing isolates are high in community-acquired urinary infections in Assam as detected by a novel multiplex polymerase chain reaction assay.
    Borah VV; Saikia KK; Chandra P; Hazarika NK; Chakravarty R
    Indian J Med Microbiol; 2016; 34(2):173-82. PubMed ID: 27080768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distribution of extended-spectrum β-lactam, quinolone and carbapenem resistance genes, and genetic diversity among uropathogenic Escherichia coli isolates in Tehran, Iran.
    Shahbazi S; Asadi Karam MR; Habibi M; Talebi A; Bouzari S
    J Glob Antimicrob Resist; 2018 Sep; 14():118-125. PubMed ID: 29581075
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ceftibuten-induced filamentation of extended spectrum beta lactamase (ESBL)-producing uropathogenic Escherichia coli alters host cell responses during an in vitro infection.
    Demirel I; Kruse R; Önnberg A; Persson K
    Microb Pathog; 2015 Jan; 78():52-62. PubMed ID: 25433242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clonal groups of extended-spectrum β-lactamase and biofilm producing uropathogenic
    Qasemi A; Rahimi F; Katouli M
    Pathog Glob Health; 2022 Dec; 116(8):485-497. PubMed ID: 34904540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antimicrobial Resistance Pattern and Genetic Characteristics of ESBL and Carbapenemase-producing Escherichia coli at a Tertiary Care Hospital in Bangladesh.
    Khan ER; Paul SK; Kobayashi N; Khan TR; Rahman MH; Rahman MM
    Mymensingh Med J; 2020 Jan; 29(1):37-42. PubMed ID: 31915333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changing prevalence of Escherichia coli with CTX-M-type extended-spectrum beta-lactamases in outpatient urinary E. coli between 2003 and 2008.
    Qi C; Pilla V; Yu JH; Reed K
    Diagn Microbiol Infect Dis; 2010 May; 67(1):87-91. PubMed ID: 20227224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical significance and phylogenetic background of extended spectrum β-lactamase producing Escherichia coli isolates from extra-intestinal infections.
    Chakraborty A; Adhikari P; Shenoy S; Saralaya V
    J Infect Public Health; 2015; 8(3):248-53. PubMed ID: 25466593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Phenotypic and molecular identification of extended-spectrum beta-lactamase (ESBL) TEM and SHV produced by clinical isolates Escherichia coli and Klebsiella spp. in hospitals].
    González Mesa L; Ramos Morí A; Nadal Becerra L; Morffi Figueroa J; Hernández Robledo E; Alvarez AB; Marchena Bequer JJ; González Alemán M; Villain Plous C
    Rev Cubana Med Trop; 2007; 59(1):52-8. PubMed ID: 23427419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phenotypic and Genotypic Characterization of Extended-Spectrum Beta-Lactamases Produced by
    Ghaddar N; Anastasiadis E; Halimeh R; Ghaddar A; Matar GM; Abou Fayad A; Sherri N; Dhar R; AlFouzan W; Yusef H; El Chaar M
    Infect Dis Obstet Gynecol; 2020; 2020():4190306. PubMed ID: 32327921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Investigation of beta-lactamase genes and clonal relationship among the extended-spectrum beta-lactamase producing nosocomial Escherichia coli isolates].
    Görgeç S; Kuzucu Ç; Otlu B; Yetkin F; Ersoy Y
    Mikrobiyol Bul; 2015 Jan; 49(1):15-25. PubMed ID: 25706727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extended-Spectrum β-Lactamase-Producing
    Rizk MA; Zaki MES; Mohamed HAA; Abdel-Hady DM; Montasser K
    Infect Disord Drug Targets; 2023; 23(3):e041122210656. PubMed ID: 36336807
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and Antibiotic Susceptibility Patterns of Extended-Spectrum ß-Lactamase and Metallo-ß-Lactamase-Producing Uropathogenic Escherichia coli Isolates.
    Ghadiri H; Vaez H; Razavi-Azarkhiavi K; Rezaee R; Haji-Noormohammadi M; Rahimi AA; Vaez V; Kalantar E
    Lab Med; 2014; 45(4):291-6. PubMed ID: 25316659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CTX-M-32 beta-lactamase-producing uropathogenic Escherichia coli isolated in Latin America.
    Araque M; Millán B; Mendoza E; Salas M
    J Infect Dev Ctries; 2013 May; 7(5):432-5. PubMed ID: 23669435
    [No Abstract]   [Full Text] [Related]  

  • 39. Iodometric and Molecular Detection of ESBL Production Among Clinical Isolates of E. coli Fingerprinted by ERIC-PCR: The First Egyptian Report Declares the Emergence of E. coli O25b-ST131clone Harboring bla
    El-Badawy MF; Tawakol WM; Maghrabi IA; Mansy MS; Shohayeb MM; Ashour MS
    Microb Drug Resist; 2017 Sep; 23(6):703-717. PubMed ID: 28099061
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of β-Lactamase Producing Escherichia coli from Retail Meat in Turkey.
    Pehlivanlar Önen S; Aslantaş Ö; Şebnem Yılmaz E; Kürekci C
    J Food Sci; 2015 Sep; 80(9):M2023-9. PubMed ID: 26256548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.